Cancer Therapy with Checkpoint Inhibitors: Establishing a Role for Ophthalmology

摘要

Objective To discuss interprofessional collaboration between the primary oncology clinicians and specialists in the management of immune-related ocular toxicities. Data Sources Peer-reviewed articles, case reports and systematic reviews. Conclusion Accurate ophthalmologic assessment is critical for the prevention and treatment of ocular toxicities associated with immunotherapy. Implications for Nursing Practice Oncology nurses play a key role in early identification and management of ocular symptoms from immunotherapy; early referral to ophthalmic specialists can enhance recovery and preserve sight.